Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 672 of 672 entries
View as:

Tenofovir Disoproxil Fumarate (Tenofovir DF) Versus Emtricitabine/Tenofovir DF in Subjects Resistant to Lamivudine

Phase: N/A Priority: Normal
NCT ID: NCT00737568 Org: User:
Start: 09/30/08 End: 02/28/15 Due: 02/28/16

Sofosbuvir Plus Ribavirin in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection

Phase: N/A Priority: Normal
NCT ID: NCT01713283 Org: User:
Start: 10/31/12 End: 02/28/14 Due: 02/28/15

Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00002419 Org: User:
Start: - End: - Due: -

Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir

Phase: N/A Priority: Normal
NCT ID: NCT00708162 Org: User:
Start: 07/31/08 End: 04/30/15 Due: 04/30/16

ProphyALL - Study on the Safety of Liposomal Amphotericin B to Prevent Antifungal Infections in Elderly Patients With Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00386997 Org: User:
Start: 11/30/06 End: 09/30/07 Due: 09/30/08

Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed Children

Phase: N/A Priority: Normal
NCT ID: NCT01854775 Org: User:
Start: 05/06/13 End: 06/30/25 Due: 06/30/26

Absolute Bioavailability, Safety, and Tolerability of Subcutaneous GS-5745 in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT02209987 Org: User:
Start: 08/31/14 End: 10/31/14 Due: 10/31/15

Entospletinib Monotherapy and in Combination With Chemotherapy in Adults With Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT02343939 Org: User:
Start: 07/01/15 End: 02/21/19 Due: 02/21/20

Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 Coinfection

Phase: N/A Priority: Normal
NCT ID: NCT02480712 Org: User:
Start: 07/01/15 End: 06/22/16 Due: 06/22/17

Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination (FDC) for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic HCV Infection

Phase: N/A Priority: Normal
NCT ID: NCT02251717 Org: User:
Start: 10/14/14 End: 06/16/16 Due: 06/16/17

Efficacy and Safety of Ledipasvir/Sofosbuvir, With or Without Ribavirin, in HCV Infected Participants Who Have Failed Prior Treatment With Sofosbuvir-based Therapies

Phase: N/A Priority: Normal
NCT ID: NCT02600351 Org: User:
Start: 11/11/15 End: 05/29/17 Due: 05/29/18

Dose Optimization Study of Idelalisib in Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02536300 Org: User:
Start: 01/14/16 End: 09/27/22 Due: 09/27/23

Safety and Efficacy of GS-4774 in Combination With Tenofovir Disoproxil Fumarate (TDF) for the Treatment of Participants With Chronic Hepatitis B (CHB) and Who Are Currently Not on Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02174276 Org: User:
Start: 07/24/14 End: 05/30/18 Due: 05/30/19

Sofosbuvir With Pegylated Interferon and Ribavirin Hepatitis C Virus (HCV) Genotypes 1,4,5,6

Phase: N/A Priority: Normal
NCT ID: NCT01329978 Org: User:
Start: 03/31/11 End: 08/31/12 Due: 08/31/13

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the Treatment of HCV

Phase: N/A Priority: Normal
NCT ID: NCT01701401 Org: User:
Start: 09/30/12 End: 04/30/14 Due: 04/30/15

Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19)

Phase: N/A Priority: Normal
NCT ID: NCT04745351 Org: User:
Start: 03/31/21 End: 05/24/22 Due: 05/24/23

Ranolazine SR in Patients With Chronic Angina Who Remain Symptomatic Despite Maximal Treatment With Amlodipine

Phase: N/A Priority: Normal
NCT ID: NCT00091429 Org: User:
Start: 08/31/04 End: 02/28/05 Due: 02/28/06

Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Phase: N/A Priority: Normal
NCT ID: NCT01440569 Org: User:
Start: 09/30/11 End: 10/31/15 Due: 10/31/16

Single Cohort 4-period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine

Phase: N/A Priority: Normal
NCT ID: NCT01546597 Org: User:
Start: 02/29/12 End: 03/31/12 Due: 03/31/13

Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination in Participants With Chronic Hepatitis C Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT02722837 Org: User:
Start: 04/04/16 End: 09/13/17 Due: 09/13/18

Study to Evaluate Safety and Pharmacokinetics of GS-4059 (Tirabrutinib) in Healthy Volunteers and Participants With Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal
NCT ID: NCT02626026 Org: User:
Start: 01/26/16 End: 09/01/16 Due: 09/01/17

Trial of Magrolimab (Hu5F9-G4) in Combination With Rituximab or Rituximab + Chemotherapy in Participants With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02953509 Org: User:
Start: 11/21/16 End: 03/25/24 Due: 03/25/25